| Maria Constantinou, MD | |
|
593 Eddy St, Apc Building, Providence, RI 02903-4923 | |
| (401) 444-5396 | |
| (401) 444-8918 |
| Full Name | Maria Constantinou |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 27 Years |
| Location | 593 Eddy St, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407999444 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD10436 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rhode Island Hospital | Providence, RI | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| Newport Hospital | Newport, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rhode Island Hospital | 8921900044 | 303 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today that it will be presenting and exhibiting at the SAP Insider Logistics and Supply Chain Conference in Orlando, Florida on February 22-26, 2010.
Fighting sudden cardiac arrest (SCA) in schools has been a business and social imperative for Cardiac Science since the company's founding. The reason is clear: Studies show that one in 50 high schools has had a SCA incident–either student or faculty–on school grounds each year–according to Parent Heart Watch, a CPR/AED Advocacy Group.
AIDS Healthcare Foundation (AHF) , which operates the largest community-based alternative HIV and sexually transmitted disease (STD) testing program in California, has launched an innovative and eye-catching Los Angeles-area HIV prevention and testing campaign urging the public to "Stay Negative" and to visit www.freehivtest.net to find out where to get tested quickly, conveniently and at no cost.
Hypertrophic cardiomyopathy (HCM), an abnormal thickening of the heart, affects more than 500,000 Americans, making it more common than better-known conditions such as Crohn's disease, Multiple Sclerosis and Anorexia Nervosa.
Researchers have closed a randomized clinical trial comparing gefitinib (Iressa) vs. placebo following chemotherapy and radiation for patients with non-small cell lung cancer (NSCLC) that had spread only to nearby tissues or lymph nodes. Review of interim data indicated that gefitinib would not improve survival.
› Verified 2 days ago
| Entity Name | Brown Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689626764 PECOS PAC ID: 0446159776 Enrollment ID: O20040219000354 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today that it will be presenting and exhibiting at the SAP Insider Logistics and Supply Chain Conference in Orlando, Florida on February 22-26, 2010.
Fighting sudden cardiac arrest (SCA) in schools has been a business and social imperative for Cardiac Science since the company's founding. The reason is clear: Studies show that one in 50 high schools has had a SCA incident–either student or faculty–on school grounds each year–according to Parent Heart Watch, a CPR/AED Advocacy Group.
AIDS Healthcare Foundation (AHF) , which operates the largest community-based alternative HIV and sexually transmitted disease (STD) testing program in California, has launched an innovative and eye-catching Los Angeles-area HIV prevention and testing campaign urging the public to "Stay Negative" and to visit www.freehivtest.net to find out where to get tested quickly, conveniently and at no cost.
Hypertrophic cardiomyopathy (HCM), an abnormal thickening of the heart, affects more than 500,000 Americans, making it more common than better-known conditions such as Crohn's disease, Multiple Sclerosis and Anorexia Nervosa.
Researchers have closed a randomized clinical trial comparing gefitinib (Iressa) vs. placebo following chemotherapy and radiation for patients with non-small cell lung cancer (NSCLC) that had spread only to nearby tissues or lymph nodes. Review of interim data indicated that gefitinib would not improve survival.
› Verified 2 days ago
| Entity Name | Rhode Island Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396849782 PECOS PAC ID: 8921900044 Enrollment ID: O20050211000311 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today that it will be presenting and exhibiting at the SAP Insider Logistics and Supply Chain Conference in Orlando, Florida on February 22-26, 2010.
Fighting sudden cardiac arrest (SCA) in schools has been a business and social imperative for Cardiac Science since the company's founding. The reason is clear: Studies show that one in 50 high schools has had a SCA incident–either student or faculty–on school grounds each year–according to Parent Heart Watch, a CPR/AED Advocacy Group.
AIDS Healthcare Foundation (AHF) , which operates the largest community-based alternative HIV and sexually transmitted disease (STD) testing program in California, has launched an innovative and eye-catching Los Angeles-area HIV prevention and testing campaign urging the public to "Stay Negative" and to visit www.freehivtest.net to find out where to get tested quickly, conveniently and at no cost.
Hypertrophic cardiomyopathy (HCM), an abnormal thickening of the heart, affects more than 500,000 Americans, making it more common than better-known conditions such as Crohn's disease, Multiple Sclerosis and Anorexia Nervosa.
Researchers have closed a randomized clinical trial comparing gefitinib (Iressa) vs. placebo following chemotherapy and radiation for patients with non-small cell lung cancer (NSCLC) that had spread only to nearby tissues or lymph nodes. Review of interim data indicated that gefitinib would not improve survival.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maria Constantinou, MD 593 Eddy St, Apc Building, Providence, RI 02903-4923 Ph: (401) 444-5396 | Maria Constantinou, MD 593 Eddy St, Apc Building, Providence, RI 02903-4923 Ph: (401) 444-5396 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today that it will be presenting and exhibiting at the SAP Insider Logistics and Supply Chain Conference in Orlando, Florida on February 22-26, 2010.
Fighting sudden cardiac arrest (SCA) in schools has been a business and social imperative for Cardiac Science since the company's founding. The reason is clear: Studies show that one in 50 high schools has had a SCA incident–either student or faculty–on school grounds each year–according to Parent Heart Watch, a CPR/AED Advocacy Group.
AIDS Healthcare Foundation (AHF) , which operates the largest community-based alternative HIV and sexually transmitted disease (STD) testing program in California, has launched an innovative and eye-catching Los Angeles-area HIV prevention and testing campaign urging the public to "Stay Negative" and to visit www.freehivtest.net to find out where to get tested quickly, conveniently and at no cost.
Hypertrophic cardiomyopathy (HCM), an abnormal thickening of the heart, affects more than 500,000 Americans, making it more common than better-known conditions such as Crohn's disease, Multiple Sclerosis and Anorexia Nervosa.
Researchers have closed a randomized clinical trial comparing gefitinib (Iressa) vs. placebo following chemotherapy and radiation for patients with non-small cell lung cancer (NSCLC) that had spread only to nearby tissues or lymph nodes. Review of interim data indicated that gefitinib would not improve survival.
› Verified 2 days ago
Christopher Donald Palmer, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1122 Fax: 401-453-7597 | |
Martha Catherine Trimbur, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 245 Chapman St Ste 300, Providence, RI 02905 Phone: 401-444-4741 Fax: 401-444-4445 | |
Karl Herman, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 164 Summit Ave, Fain Bldg., Providence, RI 02906 Phone: 401-793-4489 Fax: 401-793-4047 | |
Muhammad Baig, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 164 Summit Ave, Fain Bldg, Providence, RI 02906 Phone: 401-793-4489 Fax: 401-793-4047 | |
Dr. Peter Sidhom, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 825 Chalkstone Ave, Providence, RI 02908 Phone: 603-560-2276 | |
Dr. Kanhai Farrakhan, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-457-3336 Fax: 401-525-2349 | |
Gary M Katzman, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 208 Collyer Street, Suite 100, Providence, RI 02904 Phone: 401-793-7191 Fax: 401-793-7200 |